[go: up one dir, main page]

MX2018007124A - Mezcla de hmo. - Google Patents

Mezcla de hmo.

Info

Publication number
MX2018007124A
MX2018007124A MX2018007124A MX2018007124A MX2018007124A MX 2018007124 A MX2018007124 A MX 2018007124A MX 2018007124 A MX2018007124 A MX 2018007124A MX 2018007124 A MX2018007124 A MX 2018007124A MX 2018007124 A MX2018007124 A MX 2018007124A
Authority
MX
Mexico
Prior art keywords
mixture
hmos
dfl
human
lnnt
Prior art date
Application number
MX2018007124A
Other languages
English (en)
Other versions
MX377225B (es
Inventor
Mcconnell Bruce
Kristine Vigsnaes Louise
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57543057&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2018007124(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2018007124A publication Critical patent/MX2018007124A/es
Publication of MX377225B publication Critical patent/MX377225B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/195—Proteins from microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Otolaryngology (AREA)
  • Pediatric Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Saccharide Compounds (AREA)
  • Dairy Products (AREA)

Abstract

La invención se refiere a una mezcla de oligosacáridos de la leche humana y una composición que los comprende, que consiste esencialmente en: LNnT, LNT, 2'-FL,3'-SL, 6'-SL y ya sea DFL o 3-FL, preferentemente DFL, que puede ser útil para prevenir y/o tratar infecciones virales y/o bacterianas en un ser humano.
MX2018007124A 2015-12-15 2016-12-15 Mezcla sintetica de oligosacaridos de la leche humana (hmo) y composición que la contiene. MX377225B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15200067 2015-12-15
EP16154144 2016-02-03
PCT/EP2016/081308 WO2017103019A1 (en) 2015-12-15 2016-12-15 Mixture of hmos

Publications (2)

Publication Number Publication Date
MX2018007124A true MX2018007124A (es) 2018-09-07
MX377225B MX377225B (es) 2025-03-07

Family

ID=57543057

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018007124A MX377225B (es) 2015-12-15 2016-12-15 Mezcla sintetica de oligosacaridos de la leche humana (hmo) y composición que la contiene.

Country Status (13)

Country Link
US (4) US11957148B2 (es)
EP (2) EP3389668A4 (es)
CN (3) CN116059221A (es)
AU (2) AU2016372446B2 (es)
BR (1) BR112018010505B1 (es)
CL (1) CL2018001549A1 (es)
ES (1) ES2759556T3 (es)
MX (1) MX377225B (es)
MY (1) MY186217A (es)
PH (1) PH12018501221A1 (es)
PT (1) PT3389404T (es)
WO (2) WO2017103850A1 (es)
ZA (1) ZA201804691B (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2999358B1 (en) * 2013-05-22 2021-07-07 Glycom A/S Synthetic mixture of oligosaccharides for the treating a microbiota of a mammal
WO2017103850A1 (en) 2015-12-15 2017-06-22 Glycom A/S Mixture of hmos
US20180103675A1 (en) * 2016-10-14 2018-04-19 Mead Johnson Nutrition Company Personalized pediatric nutrition products comprising human milk oligosaccharides
WO2019106147A1 (en) * 2017-12-01 2019-06-06 Nestec S.A. Human milk fortifier composition
CN111556755A (zh) * 2017-12-05 2020-08-18 格礼卡姆股份公司 用于治疗偏头痛的人乳寡糖
ES3039685T3 (en) * 2017-12-08 2025-10-23 Chr Hansen Hmo Gmbh Spray-dried tetrasaccharides
EP3494807A1 (en) * 2017-12-11 2019-06-12 Jennewein Biotechnologie GmbH Spray-dried sialyllactose
PL3494804T3 (pl) * 2017-12-08 2025-10-06 Chr. Hansen HMO GmbH Suszona rozpyłowo 3-fukozylolaktoza
JP2021505174A (ja) 2017-12-08 2021-02-18 イェンネワイン バイオテクノロジー ゲーエムベーハーＪｅｎｎｅｗｅｉｎ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅ ＧｍｂＨ 噴霧乾燥ラクト−ｎ−フコペンタオース
CN111432661A (zh) 2017-12-22 2020-07-17 雀巢产品有限公司 用途是用于减少婴儿和幼儿的伤害感觉的组合物
PL3524067T3 (pl) 2018-02-08 2025-06-09 Chr. Hansen HMO GmbH Suszona rozpyłowo mieszanina oligosacharydów mleka ludzkiego
US11642359B2 (en) 2018-07-12 2023-05-09 N.V. Nutricia Nutritional composition for improving intestinal barrier integrity, preparation of the composition and method of treatment
AU2019407214B2 (en) * 2018-12-21 2025-04-24 Societe Des Produits Nestle S.A. A nutritional composition comprising metabolites of HMOs to improve the gastrointestinal barrier
ES3028208T3 (en) * 2018-12-21 2025-06-18 Nestle Sa A nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier
CN113163833A (zh) * 2018-12-21 2021-07-23 雀巢产品有限公司 包含6′sl和lnt的组合以改善胃肠屏障功能的营养组合物
CN113194961A (zh) * 2018-12-21 2021-07-30 格礼卡姆股份公司 用于促进肠道屏障愈合的组合物和方法
US20220022515A1 (en) 2019-02-25 2022-01-27 Nutribam Bv Composition, Food Supplement and Method for Supporting and/or Improving Intestinal Health
BE1027078A9 (nl) * 2019-02-25 2020-09-28 Nutribam Bvba Samenstelling, voedingssupplement en werkwijze voor het ondersteunen en/of verbeteren van de darmgezondheid
WO2020178774A1 (en) * 2019-03-05 2020-09-10 Glycom A/S Human milk oligosaccharides for use in enhancing executive function
ES1240969Y (es) * 2019-09-18 2020-07-30 Jennewein Biotechnologie Gmbh Composiciones de cereales que contienen oligosacaridos de la leche humana
KR20220107011A (ko) * 2019-11-29 2022-08-01 글리콤 에이/에스 임산부의 미생물총을 개선하기 위한 hmo의 혼합물
CN112870233B (zh) * 2019-11-29 2024-08-23 伊利伊诺科技(上海)有限责任公司 包含乳双歧杆菌与母乳低聚糖的组合物及其应用
CN112515170B (zh) * 2019-11-29 2023-02-21 伊利伊诺科技(上海)有限责任公司 提高胃肠道免疫能力的乳双歧杆菌与益生元组合物及应用
BR112022016589A2 (pt) * 2019-12-06 2022-10-11 Glycom As Composição que compreende 2?-fl e dfl para uso em um método para reduzir a dor
BR112022008956A2 (pt) * 2019-12-06 2022-08-02 Nestle Sa Composições para uso na redução de dor e/ou percepção de dor em bebês e crianças pequenas
WO2021115990A1 (en) * 2019-12-09 2021-06-17 Société des Produits Nestlé S.A. Compositions comprising human milk oligosaccharides for use in a subject to support language development
CN114786501A (zh) * 2019-12-11 2022-07-22 雀巢产品有限公司 用于减少婴儿和幼儿的伤害感觉和/或其他健康益处的组合物
GB2590375B (en) * 2019-12-11 2024-05-08 Mjn Us Holdings Llc Staged nutritional compositions containing human milk oligosaccharides and uses thereof
JP7516053B2 (ja) * 2020-01-20 2024-07-16 森永乳業株式会社 組成物並びに飲食品組成物、栄養組成物および調製乳
CN113519849B (zh) * 2020-04-14 2023-04-07 内蒙古伊利实业集团股份有限公司 提升肠道对大肠杆菌感染的抵御力的母乳低聚糖及其应用
CN112075637B (zh) * 2020-04-27 2023-05-23 合生元（广州）健康产品有限公司 一种减少肠道气体产生的组合物
CN116391026A (zh) * 2020-06-26 2023-07-04 雀巢产品有限公司 产生丝氨酸蛋白酶抑制剂
EP4228436A1 (en) * 2020-10-16 2023-08-23 Société des Produits Nestlé S.A. Nutritional composition comprising human milk oligosaccharides
CN114431484A (zh) * 2020-11-06 2022-05-06 内蒙古伊利实业集团股份有限公司 人乳寡糖在提高肠道对沙门氏菌感染抵御能力中的应用
JP2023547175A (ja) * 2020-11-10 2023-11-09 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 栄養組成物
CN114504109B (zh) * 2020-11-16 2024-02-09 内蒙古伊利实业集团股份有限公司 一种含乳双歧杆菌与母乳低聚糖的组合物及其应用
US20240000122A1 (en) * 2020-12-04 2024-01-04 Societe Des Produits Nestle S.A. Compositions comprising human milk oligosaccharides for use in a subject to support night sleep duration
AU2021403857A1 (en) * 2020-12-18 2023-06-08 Société des Produits Nestlé S.A. Compositions for use in promoting accelerated butyrate production in young children
EP4266905A1 (en) * 2020-12-22 2023-11-01 Intrinsic Medicine, Inc. Immunomodulatory oligosaccharides for the enhancement of anti-tumor efficacy of immuno-oncology agents
MX2023008202A (es) * 2021-01-29 2023-07-18 Nestle Sa Mezcla de hmo y bifidobacteria.
WO2022254016A1 (en) 2021-06-04 2022-12-08 N.V. Nutricia Infant formula for feeding infants receiving infant formula and human breast milk
WO2023066907A1 (en) 2021-10-18 2023-04-27 Dsm Ip Assets B.V. A method for providing an amorphous hmo product by drying
CN114223723A (zh) * 2021-12-13 2022-03-25 黑龙江飞鹤乳业有限公司 营养组合物、包含其的食品以及该营养组合物的用途
DE102021134539A1 (de) 2021-12-23 2023-06-29 AASAYA LifeScience GmbH Synbiotikum zur Anwendung in einem Therapieverfahren
WO2024064327A1 (en) * 2022-09-22 2024-03-28 Abbott Laboratories Human milk oligosaccharides for enhancing blood-brain barrier function
CN116602409B (zh) * 2023-02-20 2024-04-05 合生元（广州）健康产品有限公司 一种抑制轮状病毒感染的组合物
CN121078987A (zh) * 2023-04-28 2025-12-05 雀巢产品有限公司 用于个体的组合物
CN121419685A (zh) * 2023-07-06 2026-01-27 雀巢产品有限公司 用于肠道健康的饮食管理的组合
CN118104826A (zh) * 2023-12-29 2024-05-31 澳优乳业（中国）有限公司 一种用于改善神经发育和功能障碍的低聚糖组合物
WO2025196272A1 (en) * 2024-03-22 2025-09-25 Dsm Ip Assets B.V. Combination of mixtures of hmos with mfgm and their use
WO2025233455A1 (en) 2024-05-08 2025-11-13 N.V. Nutricia Nutritional composition for strenghtening the gut barrier
WO2026013116A1 (en) 2024-07-09 2026-01-15 N.V. Nutricia Lacto-n-fucopentaose i (lnfp-i) for use in lung cancer treatment
CN119454723A (zh) * 2024-10-17 2025-02-18 嘉必优生物技术（武汉）股份有限公司 母乳低聚糖在制备抑制肠道Ruminococcus增殖的制剂中的应用
CN119138609B (zh) * 2024-11-19 2025-02-25 飞鹤(吉林)乳品有限公司 母乳低聚糖改善母婴肠道菌群的用途

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686684A (ja) 1992-05-26 1994-03-29 Monsanto Co シアロ抱合体の合成
US6045854A (en) 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
PT1629850E (pt) 2004-08-24 2007-08-14 Nutricia Nv Composição nutricional que compreende a administração de oligossacarídeos indigeríveis
EP1991690B1 (en) 2006-03-09 2014-01-15 Centre National De La Recherche Scientifique (Cnrs) Method of producing sialylated oligosaccharides
EP2060257A1 (en) 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
WO2009082214A1 (en) 2007-12-21 2009-07-02 N.V. Nutricia Use of non-digestible carbohydrates for improving intestinal microbiota
WO2010002241A1 (en) * 2008-06-30 2010-01-07 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
JP5711128B2 (ja) 2008-09-22 2015-04-30 エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． ペプチド模倣大環状分子
CN102459294A (zh) 2009-04-07 2012-05-16 格礼卡姆股份公司 2’-o-岩藻糖基乳糖的合成
KR20120138772A (ko) 2010-02-19 2012-12-26 글리콤 에이/에스 ６’?ｏ?시알릴락토오스 및 중간체의 제조
CN102803282A (zh) 2010-02-19 2012-11-28 格礼卡姆股份公司 用于制备含n-乙酰乳糖胺的四糖乳糖-n-新四糖(lnnt)的方法
CA2792112C (en) 2010-03-12 2018-09-04 Dsm Ip Assets B.V. Maternal sialic acid supplementation
EP2465509A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating acute respiratory tract infections
EP2454948A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
SG191792A1 (en) * 2010-12-31 2013-08-30 Abbott Lab Human milk oligosaccharides for modulating inflammation
WO2012092157A2 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
MY166946A (en) 2010-12-31 2018-07-25 Abbott Lab Methods of using human milk oligosaccharides for improving airway respiratory health
DK2658549T3 (da) 2010-12-31 2020-06-29 Abbott Lab Fremgangsmåder til reduktion af incidensen af oxidativt stress under anvendelse af humane mælkeoligosaccharider, vitamin c og anti-inflammatoriske midler
SG10201707519PA (en) * 2010-12-31 2017-10-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
ES2692533T3 (es) * 2011-02-10 2018-12-04 Nestec S.A. Modulación del crecimiento de las bífidobacterias mediante una combinación de oligosacáridos de la leche humana
CA2835989A1 (en) 2011-05-13 2012-11-22 Glycom A/S Diversification of human milk oligosaccharides (hmos) or precursors thereof
CN103703012A (zh) 2011-05-13 2014-04-02 格礼卡姆股份公司 乳糖-n-四糖的制造
EP2525364A1 (en) 2011-05-20 2012-11-21 Areva NP Nuclear fuel assembly having varying spacing between fuel rods
SG2014013478A (en) 2011-08-29 2014-05-29 Abbott Lab Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
US20140235850A1 (en) 2011-09-30 2014-08-21 Glycom A/S Synthesis of hmo core structures
PH12014500443A1 (en) 2011-10-18 2014-04-14 Socia‰Ta‰ Des Produits Nestla‰ S A Composition for use in brain growth and/or cognitive and/or psychomotor development
ES2560023T3 (es) 2011-10-18 2016-02-17 Nestec S.A. Composición para su uso para incrementar la sensibilidad a la insulina y / o para reducir la resistencia a la insulina
WO2013091660A1 (en) 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
US20150065702A1 (en) 2012-03-20 2015-03-05 Glycom A/S Synthesis of the Trisaccharide 3-O-Fucosyllactose and Intermediates Thereof
JP2015512936A (ja) 2012-04-13 2015-04-30 トラスティーズ オブ ボストン カレッジ プレバイオティクス組成物およびその使用方法
WO2013185780A1 (en) * 2012-06-14 2013-12-19 Glycom A/S Enhancing the stability and purity and increasing the bioavailability of human milk oligosaccharides or precursors or blends thereof
EP3936134A1 (en) 2012-11-02 2022-01-12 N.V. Nutricia Synbiotics combination for brain improvement
EP2931737A4 (en) * 2012-12-14 2016-11-16 Glycom As MIXTURE FROM FUCOSYLATE LACTOSES
CN104955344A (zh) 2012-12-18 2015-09-30 雅培制药有限公司 包含神经保护膳食寡糖的营养组合物
EP2999358B1 (en) * 2013-05-22 2021-07-07 Glycom A/S Synthetic mixture of oligosaccharides for the treating a microbiota of a mammal
EP3041946B2 (en) 2013-09-06 2025-07-30 Glycom A/S Fermentative production of oligosaccharides
AU2014350157A1 (en) * 2013-11-15 2016-04-14 Nestec S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
ES2916813T3 (es) 2013-11-15 2022-07-06 Nestle Sa Composiciones para uso en la prevención o tratamiento de enterocolitis necrotizante en lactantes y niños pequeños
US10940158B2 (en) * 2013-11-15 2021-03-09 Societe Des Produits Nestle S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by C-section
CN105744939A (zh) 2013-11-15 2016-07-06 雀巢产品技术援助有限公司 用于治疗或预防流行性感冒感染的含有2-岩藻糖基化低聚糖的婴儿配方食品
EP3068404B1 (en) 2013-11-15 2021-01-06 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of urt infections in infants or young children at risk
EP2888950A1 (en) 2013-12-24 2015-07-01 Abbott Laboratories Methods for treating, preventing, or reducing neuroinflammation or cognitive impairment
US20170202864A1 (en) * 2014-07-21 2017-07-20 Abbott Laboratories Nutrient delivery system with human milk oligosaccharides
US11040049B2 (en) * 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US11040050B2 (en) * 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
WO2016138911A1 (en) * 2015-03-05 2016-09-09 Glycom A/S Composition and method for treating acute respiratory tract infections
US10751354B2 (en) * 2015-09-14 2020-08-25 Glycom A/S Synthetic composition for microbiota modulation
WO2017103850A1 (en) 2015-12-15 2017-06-22 Glycom A/S Mixture of hmos
US11278558B2 (en) * 2017-03-01 2022-03-22 Glycom A/S Synthetic composition for microbiota modulation
EP3634156B1 (en) 2017-05-09 2025-03-12 Société des Produits Nestlé S.A. Synergistic production of butyrate associated with the complexity of hmos blend for use in infants or young children for health purposes

Also Published As

Publication number Publication date
EP3389668A4 (en) 2019-08-21
US20180368460A1 (en) 2018-12-27
ZA201804691B (en) 2020-07-29
ES2759556T3 (es) 2020-05-11
RU2018125567A (ru) 2020-01-16
PT3389404T (pt) 2020-01-14
US11957148B2 (en) 2024-04-16
AU2016372446B2 (en) 2021-05-20
CN108541221A (zh) 2018-09-14
US20240407419A1 (en) 2024-12-12
AU2021218066A1 (en) 2021-09-09
WO2017103850A1 (en) 2017-06-22
US11432578B2 (en) 2022-09-06
PH12018501221A1 (en) 2019-01-28
CN116059221A (zh) 2023-05-05
EP3389404A1 (en) 2018-10-24
CN108289492A (zh) 2018-07-17
RU2018125567A3 (es) 2020-04-13
US20230000127A1 (en) 2023-01-05
MX377225B (es) 2025-03-07
AU2016372446A1 (en) 2018-05-10
US20200260771A1 (en) 2020-08-20
CN108541221B (zh) 2023-02-28
WO2017103019A1 (en) 2017-06-22
BR112018010505A2 (pt) 2018-11-13
EP3389404B1 (en) 2019-10-02
EP3389668A1 (en) 2018-10-24
US12063949B2 (en) 2024-08-20
MY186217A (en) 2021-06-30
CL2018001549A1 (es) 2018-08-03
BR112018010505B1 (pt) 2021-11-16

Similar Documents

Publication Publication Date Title
MX2018007124A (es) Mezcla de hmo.
HUE043341T2 (hu) Blautia hydrogenotrophica baktériumtörzset tartalmazó készítmények, hasmenés vagy székrekedés kezelésében vagy megelõzésében történõ alkalmazásra
EP3645017A4 (en) COMPOSITIONS, PROCEDURES AND USES FOR CLEANING UP, DISINFECTING AND / OR STERILIZATION
BR112018004620A2 (pt) moduladores da expressão de kras
WO2016172658A3 (en) Microbiome regulators and related uses thereof
WO2016033439A3 (en) Compositions and methods for the treating an inflammatory disease or disorder
PH12017550040A1 (en) Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children
WO2015148863A3 (en) Crispr/cas-related methods and compositions for treating sickle cell disease
MX380540B (es) Composiciones para uso en la prevención o el tratamiento de otitis o bronquitis en infantes o niños pequeños.
EA201270803A1 (ru) Тиоацетатные соединения, композиции на их основе и способы их применения
EP3474861A4 (en) COMPOUNDS COMPRISING HMOS FOR THE PREVENTION AND / OR TREATMENT OF VIRAL AND / OR BACTERIAL INFECTIONS.
MX389207B (es) Composiciones de nicotinamida ribósido y pteroestilbeno y métodos para el tratamiento de trastornos de la piel.
HK1246800A1 (zh) 用於营养组合物的寡糖组合物和其制造方法
BR112017000024A2 (pt) composição para tratamento de tecidos que compreende uma nanoemulsão polimérica de aminossiloxano
WO2019040106A3 (en) COMPOUNDS, RELATED SALTS AND METHODS FOR THE TREATMENT OF DISEASES
BR112017014107A2 (pt) composição nutricional útil no tratamento de pacientes com ibd
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
BR112016012599A2 (pt) composição, e, método para tratamento ou prevenção de uma infecção por staphylococcus aureus
AR102085A1 (es) Composición nutricional para el entorno gastrointestinal para la provisión de un perfil metabólico y microbioma mejorados
MX2017005249A (es) Compuestos para usarse en el tratamiento antihelmintico.
HK1245586A1 (zh) 使用高脂肪人乳预防和治疗支气管肺发育不良的方法
WO2015159155A3 (en) Novel ademetionine formulations
EP3648603A4 (en) ANTIMICROBIAL, DISINFECTANT, AND WOUND-HEALING COMPOSITIONS AND METHOD FOR MANUFACTURING AND USING THEREOF
EP3582773A4 (en) PROCESS FOR THE MANUFACTURING OF AG-10, ITS INTERMEDIATES AND SALTS THEREOF
HK1259083A1 (zh) 用於治疗系统性肥大细胞增多症的方法和组合物

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: SOCIETE DES PRODUITS NESTLE S.A.

FG Grant or registration